Announcement PDF Rule 3.19A.2 Appendix 3Y Change of Director’s Interest Notice Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public. Introduced 30/09/01 Name of entity Amaero Inc ARBN 697 927 647 We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act. Name of Director Mr Bob Latta Date of last notice 28 August 2026 Part 1 - Change of director’s relevant interests in securities In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part. Direct or indirect interest Direct & Indirect Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. Pegasus Growth Capital Fund I - Mr Latta is a partner of Pegasus Growth Capital and holds a minority interest in the securities held by Pegasus Growth Capital Fund in Amaero International Limited. Mr Latta and his spouse have an indirect beneficial interest in approximately 6.3% of Pegasus’ total securities; and Date of change 28 August 2026 No. of securities held prior to change • 298,369,310 Fully Paid CDIs (indirect beneficial interest of 6.3% of these shares held by Pegasus); • 500,000 Options Expiring 31 October 2033, Ex. $0.190 (held directly); • 500,000 Options Expiring 8 November 2033, Ex. $0.248 (held directly); • 600,000 Options Expiring 8 November 2027, Ex. $0.348 (held directly) • 500,000 Fully Paid CDIs (held directly); and • 600,000 Options Expiring 25-Nov-2028 (held directly), ex. $0.2307 Class Restricted Stock Units Appendix 3Y Change of Director’s Interest Notice + See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 2 Number acquired 639,244 Number disposed Nil Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation Nil No. of securities held after change • 298,369,310 Fully Paid CDIs (indirect beneficial interest of 6.7% of these securities held by Pegasus); • 500,000 Options Expiring 31 October 2033, Ex. $0.190 (held directly); • 500,000 Options Expiring 8 November 2033, Ex. $0.248 (held directly); • 600,000 Options Expiring 8 November 2027, Ex. $0.348 (held directly) • 500,000 Fully Paid CDIs (held directly); • 600,000 Options Expiring 25-Nov-2028 (held directly), ex. $0.2307; and • 639,244 Restricted Stock Units, vesting 28 August 2027 (held directly). Nature of change Example: on-market trade, off- market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back 639,244 Restricted Stock Units were issued for nil consideration under Amaero’s Equity Incentive Plan following approval at the Special Meeting of Stockholders held on 28 August 2026. Part 2 – Change of director’s interests in contracts Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part. Detail of contract N/A Nature of interest N/A Name of registered holder (if issued securities) N/A Date of change N/A No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed N/A Interest acquired N/A Interest disposed N/A Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation N/A Interest after change N/A Appendix 3Y Change of Director’s Interest Notice + See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 3 Part 3 – +Closed period Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required? No If so, was prior written clearance provided to allow the trade to proceed during this period? N/A If prior written clearance was provided, on what date was this provided? N/A